Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Actavis Confirms Generic Quillivant XR Patent Challenge
Saturday, October 18, 2014Actavis plc today confirmed that it has filed an Abbreviated New Drug Application ANDA with the US Food and Drug Administration FDA seeking approval to market Methylphenidate Hydrochloride for Extendedrelease Oral Suspension mgmL Actavis ANDA produc...
AcelRx Pharmaceuticals provides update on its Patent Portfolio for Zalviso and its Proprietary Platform Technologies
Friday, October 17, 2014AcelRx Pharmaceuticals Inc a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today provided an update regarding its growing patent estate which...
Pharmaceutical Cannabidiol production by Insys Therapeutics granted DEA Approval
Friday, October 17, 2014Insys Therapeutics Inc has stated that its Food and Drug Administration FDA inspected and Drug Enforcement Agency DEA examined and approved facility in Round Rock Texas has got DEA approval to manufacture pharmaceutical grade Cannabidiol CBD syntheti...
Abott''s new facility launch in Gujarat today
Thursday, October 16, 2014The USheadquartered pharmaceutical and health care products company Abbott Laboratories is set to launch its first greenfield plant in India with an investment of Rs crore The facility coming up at Jhagadia in Bharuch district of Gujarat to manufac...
Akynzeo for prevention of chemotherapy-induced nausea & vomiting now approved by US FDA
Wednesday, October 15, 2014Akynzeo has been approved by the US Food and Drug Administration FDA for the prevention of acute and delayed nausea and vomiting related with initial and repeat courses of cancer chemotherapy that includes but not limited to highly emetogenic chemoth...
Bristol-Myers Squibb, Pharmacyclics pacts with Janssen to examine Opdivo and Imbruvica in non-Hodgkin lymphoma
Wednesday, October 15, 2014BristolMyers Squibb Company Pharmacyclics with Janssen Research Development will conduct a clinical trial to evaluate the safety tolerability and preliminary efficacy of BristolMyers Squibbs investigational PD immune checkpoint inhibitor Opdivo nivo...
AbbVie board backs out on planned $55 billion Shire take over
Wednesday, October 15, 2014US drugmaker AbbVie has held its plan to buy Shire a Dublinbased firm asking its shareholders voice against the planned billion billion pounds takeover following new US tax rules Shire still gets breakup fee of about billion in case AbbVies shar...
Phase III trial of investigational rotavirus vaccine by Shantha Biotechnics
Tuesday, October 14, 2014A phase III study was carried out with the longterm aim to produce a locally licensed vaccine that is safe and able to protect children against rotavirus gastroenteritis Overall the results showed that all three doses of the vaccine evaluated in the...
UK-based Synergy Health goes to Steris Corporation for $1.9 billion
Tuesday, October 14, 2014Global leader infection prevention Steris Corporation and Synergy Health plc quoted that Steris is initiating a recommended offer under the UK law to take over Synergy in a all cash and stock transaction in approximately about per Synergy share...
US biotech firm Biogen Idec submits Marketing Authorization Application for Elocta in Europe
Monday, October 13, 2014Swedish Orphan Biovitrum AB quoted that Biogen Idec has posted a Marketing Authorisation Application MAA for Elocta to the European Medicines Agency EMA Sobi has an exclusive optin right to presume development and commercialization of Elocta in Europ...
